Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription DrugBusiness Wire • 07/12/22
Akanda's CanMart Partners with Phlo Connect and Cellen Life Sciences to Dispense & Deliver High Quality Medical Cannabis Products in the UKBusiness Wire • 06/28/22
Akanda Announces Changes to Board of Directors and Postponement of Annual General MeetingBusiness Wire • 06/23/22
Halo Collective Reports First Quarter 2022 Financial Results; Book Value Per Share of $1.65 ($2.12 CAD)PRNewsWire • 05/17/22
Akanda Completes Acquisition of Holigen, Advancing Cannabis Leadership Position in Europe, the Middle East and Africa (EMEA)Business Wire • 05/02/22
Akanda to Acquire Portugal-based Holigen, Securing a Cannabis Sector Leadership Position in Europe, the Middle East and Africa (EMEA) with EU GMP Market AccessBusiness Wire • 04/20/22
Halo Collective Announces Westwood Dispensary Completion, Local Inspections Passed, and Planned Opening for Second Budega™ in CaliforniaPRNewsWire • 04/12/22
Halo Collective Reports 63% Revenue Growth and 345% Cannabis Sales Volume Growth in the Fourth Quarter of 2021PRNewsWire • 04/01/22
Halo Collective Congratulates Akanda Corp. on Successful First Day of Nasdaq TradingPRNewsWire • 03/16/22
Akanda Corp. Common Shares Set to Commence Trading Today on Nasdaq Under Ticker Symbol “AKAN”Business Wire • 03/15/22